≡ Menu


Prain K, Woodhall M, Vincent A et al. AQP4 antibody sensitivity comparison in the era of the 2015 diagnostic criteria for NMOSD. Frontiers in Neurology 2019, 10:1028. doi: 10.3389/fneur.2019.01028

Warren N, Swayne A, Siskind D, O’Gorman C, Prain K, Gillis D, Blum S. Serum and CSF anti-NMDAR antibody testing in psychiatry. Journal of Neuropsychiatry and Clinical Neurosciences 2019 published online 18 Sep 2019. https://doi.org/10.1176/appi.neuropsych.19030079

Tea F, Lopez JA, Ramanathan S, et al. Characterization of the epitope, affinity, and binding sensitivity of the human MOG antibody response. Acta Neuropathologica Communications 2019, 7:145. https://doi.org/10.1186/s40478-019-0786-3

Gillinder L, Warren N, Hartel G, Dionisio S, O’Gorman C. EEG findings in NMDA encephalitis – a systematic review. Seizure – European Journal of Epilepsy 2019, 65:20-24. https://doi.org/10.1016/j.seizure.2018.12.015

Warren N, Grote V, O’Gorman C, Siskind D. Electroconvulsive Therapy for Anti-N-methyl-d-aspartate (NMDA) Receptor Encephalitis: A Systematic Review of Cases. Brain Stimulation 2019 Mar – Apr;12(2):329-334. https://doi.org/10.1016/j.brs.2018.11.016

Warren N, Siskind D, O’Gorman C. Refining the psychiatric syndrome of anti-N-methyl-D-aspartate (NMDA) receptor encephalitis. Acta Psychiatrica Scandinavica 2018, 138(5):401-408. https://doi.org/10.1111/acps.12941

Warren N, O’Gorman CM, Hume Z, Kisely S, Siskind D. Delusions in Parkinson’s Disease: A systematic review of published cases. Neuropsychology Review 2018, Neuropsychol Rev. 2018 Aug 2. https://doi.org/10.1007/s11065-018-9379-3

O’Gorman CM*, Kassardjian CD*, Sorenson E. Musculocutaneous neuropathy. Muscle Nerve 2018, Jul 20. https://doi.org/10.1002/mus.26186 *joint 1st authors

Devlin M, Swayne A, Newman M, O’Gorman C, Brown H, Ong B, Robertson T, Airey C, Blum S. A case of immune-mediated encephalitis related to daclizumab therapy. Multiple Sclerosis Journal 2018, Aug 3:1352458518792403. https://doi.org/10.1177/1352458518792403

Kee R, O’Gorman C. Teaching Video NeuroImages: The pathologic deep abdominal reflex.
Neurology Nov 2017, 89 (20) e245; DOI: 10.1212/WNL.0000000000004651

Warren N, O’Gorman C, Lehn A, Siskind D. Dopamine dysregulation syndrome in Parkinson’s disease: a systematic review of published cases. J Neurol Neurosurg Psychiatry 2017, doi: 1136/ jnnp-2017-31598

Lehn AC, O’Gorman C, Olson S, Salari M. Thalamic ventral intermediate nucleus deep brain stimulation for orthostatic tremor. Tremor Other Hyperkinet Mov. 2017; 7. doi:7916/D8280JHR

Bukhari W, Prain KM, Waters P, O’Gorman CM, et al. Incidence and prevalence of NMOSD in Australia and New Zealand J Neurol Neurosurg Psychiatry Published Online First: 26 May 2017. doi: 10.1136/jnnp-2016-314839

O’Gorman CM, Weikamp JG, Baria M, Van den Engel-Hoek L, Kassardjian C, van Alfen N, Boon AJ. Detecting fasciculations in cranial nerve innervated muscles with ultrasound in Amyotrophic Lateral Sclerosis. Muscle Nerve. 2017 Apr 29. doi:
10.1002/mus.25676. [Epub ahead of print] PubMed PMID: 28457000.

O’Gorman CM, O’brien TG, Boon AJ. Utility Of diaphragm ultrasound in myopathy. Muscle Nerve. 2017 Mar;55(3):427-429. doi: 10.1002/mus.25429.

O’Gorman CM, Broadley SA. Smoking increases the risk of progression in multiple sclerosis: A cohort study in Queensland, Australia. J Neurol Sci 2016; 219-223. doi: 10.1016/j.jns.2016.09.057

Boon AJ, OʼGorman C. Ultrasound in the Assessment of Respiration. J Clin Neurophysiol. 2016 Apr;33(2):112-9. doi: 10.1097/WNP.0000000000000240. PMID: 27035251.

O’Gorman CM, Lindell EP, Van Gompel JJ, Klaas JP. A tardy tongue palsy: Delayed post-traumatic isolated unilateral hypoglossal neuropathy. Published ahead of print October 29, 2015 Neurol Clin Pract 10.1212/CPJ.0000000000000193.

Kassardjian CD*, O’Gorman CM*, Sorenson EJ. The risk of iatrogenic pneumothorax after electromyography. Muscle Nerve 2016;53(4):518-21. doi: 10.1002/mus.24883. PMID: 26333600.

O’Gorman C, Cascino GD. Teaching NeuroImages: EEG pattern associated with a skull osteolytic lesion in breast cancer. Neurology 2014 Sep 9;83(11):e117-8. doi: 10.1212/WNL.0000000000000783. PMID: 25200719.

O’Gorman C, Broadley SA. Smoking and multiple sclerosis: evidence for latitudinal and temporal variation. J Neurol 2014;261(9):1677-83. doi: 10.1007/s00415-014-7397-5. PMID: 24923244.

O’Gorman, C. M., Bower, J. H., Matsumoto, J. Y., Kantarci, O. H. and Kumar, N. (2014), When Drinking Makes the Tremor Worse: A Task-Specific Orolingual Tremor. Movement Disorders Clinical Practice 2014;1(3): 237–239. doi: 10.1002/mdc3.12041

O’Gorman C, Bukhari W, Todd A, Freeman S, Broadley SA. Smoking increases the risk of multiple sclerosis in Queensland, Australia. J Clin Neurosci 2014;21(10):1730-3. doi: 10.1016/j.jocn.2014.01.009. PMID: 24932591.

O’Gorman C. Environmental risk factors for multiple sclerosis (Part I). Revista Española de Esclerosis Múltiple 2013;28:19-36.

O’Gorman C. Environmental risk factors for multiple sclerosis (Part II). Revista Española de Esclerosis Múltiple 2014;29:5-25

O’Gorman C, Lin R, Stankovich J, Broadley SA. Modelling genetic susceptibility to multiple sclerosis with family data. Neuroepidemiology 2013;40(1):1-12. doi: 10.1159/000341902. PMID: 23075677.

O’Gorman C, Lucas R, Taylor B. Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms. Int J Mol Sci 2012;13(9):11718-52. doi: 10.3390/ijms130911718. PMID:23109880.

Fitzpatrick E, Hohl N, Silburn P, O’Gorman C, Broadley SA.. Case-control study of blink rate in Parkinson’s disease under different conditions. J Neurol 2012;259(4):739-744

O’Gorman C, Freeman S, Taylor BV, Butzkueven H; Australian and New Zealand MS Genetics Consortium (ANZgene), Broadley SA. Familial recurrence risks for multiple sclerosis in Australia. J Neurol Neurosurg Psychiatry 2011;82(12):1351-4. doi: 10.1136/jnnp.2010.233064. PMID: 21551470.

O’Gorman CM, Freeman S, Broadley SA. Use of the Addenbrooke’s Cognitive Examination in Multiple Sclerosis [Abstract]. J Clin Neurosci 2010;17(12):1617